DPP4 and diabetes mellitus: This is an important but complex issue that could not be addressed within the objectives of this systematic review, and when re-considering the use of DPP-4 inhibitors with an individual patient, the clinician must take into account any additional treatments the patient may be receiving for their diabetes.